Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,291 | 25,778 | 37,338 | 24,159 | 25,983 |
| Marketable Securities | 41,031 | 42,563 | 43,112 | 59,962 | 60,313 |
| Receivables | 898 | 705 | 417 | 218 | 286 |
| Other current assets | 20,408 | 15,282 | 6,112 | 6,067 | 6,021 |
| TOTAL | $80,628 | $84,328 | $86,979 | $90,406 | $92,603 |
| Non-Current Assets | |||||
| PPE Net | 176 | 180 | 189 | 194 | 284 |
| Other Non-Current Assets | 548 | 603 | 668 | 0 | 0 |
| TOTAL | $724 | $783 | $857 | $194 | $284 |
| Total Assets | $81,352 | $85,111 | $87,836 | $90,600 | $92,887 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,540 | 3,282 | 2,409 | 2,706 | 2,139 |
| TOTAL | $3,540 | $3,282 | $2,409 | $2,706 | $2,139 |
| Non-Current Liabilities | |||||
| TOTAL | $389 | $442 | $499 | $N/A | $N/A |
| Total Liabilities | $3,929 | $3,724 | $2,908 | $2,706 | $2,139 |
| Shareholders' Equity | |||||
| Common Shares | 58 | 58 | 58 | 58 | 58 |
| Retained earnings | -98,650 | -94,136 | -89,967 | -86,475 | -82,769 |
| Other shareholders' equity | 52 | 41 | 25 | -11 | -10 |
| TOTAL | $77,423 | $81,387 | $84,928 | $87,894 | $90,748 |
| Total Liabilities And Equity | $81,352 | $85,111 | $87,836 | $90,600 | $92,887 |